The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(39 sites)

United States

University of Alabama at Birmingham, Birmingham, Alabama

St. Joseph Hospital and Medical Center Barrow Neurological Institute, Phoenix, Arizona

Mayo Clinic in Arizona, Scottsdale, Arizona

Children's Hospital of Orange County, Orange, California

UC Irvine, Orange, California

UC Davis, Sacramento, California

Children's Hospital Colorado Main Campus, Aurora, Colorado

University of Colorado, Aurora, Colorado

Yale University, New Haven, Connecticut

Mayo Clinic Jacksonville, Jacksonville, Florida

University of Miami, Miami, Florida

Emory University, Atlanta, Georgia

Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois

Northwestern University Feinberg School of Medicine, Chicago, Illinois

University of Iowa, Iowa City, Iowa

Massachusetts General Hospital, Boston, Massachusetts

University of Michigan Health System, Ann Arbor, Michigan

Mayo Clinic Rochester, Rochester, Minnesota

Washington University in St. Louis School of Medicine, St Louis, Missouri

SUNY Downstate, Brooklyn, New York

Mount Sinai, New York, New York

Columbia University Medical Center, New York, New York

University of Rochester, Rochester, New York

SUNY Buffalo, Williamsville, New York

Wake Forest University Health Sciences, Winston-Salem, North Carolina

University of Cincinnati, Cincinnati, Ohio

Ohio State University, Columbus, Ohio

University of Pennsylvania, Philadelphia, Pennsylvania

University of Pittsburgh, Pittsburgh, Pennsylvania

Vanderbilt University, Nashville, Tennessee

University of Texas Southwestern Medical Center, Dallas, Texas

Texas Children's Hospital, Houston, Texas

University of Utah, Salt Lake City, Utah

University of Virginia, Charlottesville, Virginia

University of Washington, Seattle, Washington

Netherlands

Erasmus Medical University Center, Rotterdam

Erasmus University Rotterdam, Rotterdam

Spain

Hospital Clínic Barcelona, Barcelona

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona